MACQUARIE GROUP LTD - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2022$8,000
-11.1%
9590.0%0.00%
Q4 2021$9,000
-43.8%
9590.0%0.00%
Q3 2021$16,000
+6.7%
9590.0%0.00%
Q2 2021$15,000
-21.1%
9590.0%0.00%
Q1 2021$19,000
-5.0%
959
-14.5%
0.00%
Q4 2020$20,000
-9.1%
1,1220.0%0.00%
Q3 2020$22,000
-24.1%
1,1220.0%0.00%
Q2 2020$29,000
+163.6%
1,122
+274.0%
0.00%
Q4 2017$11,0003000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2021
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders